Zobrazeno 1 - 10
of 374
pro vyhledávání: '"Vass K"'
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics 2004 57(2):287-294
Autor:
Fitzgerald, Kathryn C., Munger, Kassandra L., Hartung, Hans peter, Freedman, Mark S., Montalbã¡n, Xavier, Edan, Gilles, Wicklein, Eva maria, Radue, Ernst wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto, Strasser fuchs, S., Berger, T., Vass, K., Sindic, C., Dubois, B., Dive, D., Debruyne, J., Metz, L., Rice, G., Duquette, P., Lapierre, Y., Freedman, M., Traboulsee, A., O'Connor, P., Å touraä, P., Talab, R., Zapletalova, O., Kovaåova, I., Medova, E., Fiedler, J., Frederiksen, J., Brochet, B., Moreau, T., Vermersch, P., Pelletier, J., Edan, G., Clanet, M., Clavelou, P., Lebrun frenay, C., Gout, O., Kallela, M., Pirttila, T., Ruutiainen, J., Koivisto, K., Reunanen, M., Elovaara, I., Villringer, A., Altenkirch, H., Wessel, K., Hartung, H. . P., Steinke, W., Kã¶lmel, H., Oschmann, P., Diem, R., Dressel, A., Hoffmann, F., Baum, K., Jung, S., Petereit, H., Reske, D., Sailer, M., Kohler, J., Sommer, N., Hohlfeld, R., Henn, K. . H., Tumani, H., Gold, R., Rieckmann, P., Komoly, R., Gacs, G., Jakab, G., Csiba, L., Vecsei, L., Miller, A., Karussis, D., Chapman, J., Ghezzi, A., Gallo, P., Cosi, V., Durelli, L., Anten, B., Visser, L., Myhr, K. . M., Szczudlik, A., Selmaj, K., Stelmasiak, Z., Podemski, R., Maciejek, Z., Cunha, L., Sega jazbec, S., Montalban, X., Arbizu, T., Saiz, A., Barcena, J., Arroyo, R., Fernandez, O., Izquierdo, G., Casanova, B., Lycke, J., Kappos, L., Mattle, H., Beer, K., Coleman, R., Chataway, J., Riordan, J. O., Howell, S., COMI, GIANCARLO
Objective: To assess whether a high-salt diet, as measured by urinary sodium concentration, is associated with faster conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) and MS activity and disability. Methods: BENEFIT was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::868859a433f78d5befd6c2b5551839ca
Wiley Online Library
Wiley Online Library
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hartung, Hp, Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kováøová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, Hf, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalba, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S. .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::784f0f348b465b09ff1d0d230995a748
http://hdl.handle.net/11577/2496642
http://hdl.handle.net/11577/2496642
Autor:
Hartung, Hp, Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kováøová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, Hf, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalba, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S. .
Publikováno v:
Neurology, 77(9), 835-843. Lippincott Williams and Wilkins
Hartung, H P, Freedman, M S, Polman, C H, Edan, G, Kappos, L, Miller, D H, Montalban, X, Barkhof, F, Petkau, J, White, R, Sahajpal, V, Knappertz, V, Beckmann, K, Lanius, V, Sandbrink, R & Pohl, C 2011, ' Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome ', Neurology, vol. 77, no. 9, pp. 835-843 . https://doi.org/10.1212/WNL.0b013e31822c90d7
Neurology, Vol. 77, no.9, p. 835-43 (2011)
Hartung, H P, Freedman, M S, Polman, C H, Edan, G, Kappos, L, Miller, D H, Montalban, X, Barkhof, F, Petkau, J, White, R, Sahajpal, V, Knappertz, V, Beckmann, K, Lanius, V, Sandbrink, R & Pohl, C 2011, ' Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome ', Neurology, vol. 77, no. 9, pp. 835-843 . https://doi.org/10.1212/WNL.0b013e31822c90d7
Neurology, Vol. 77, no.9, p. 835-43 (2011)
To determine the frequency and consequences of neutralizing antibodies (NAbs) in patients with a first event suggestive of multiple sclerosis (MS) treated with interferon β-1b (IFNβ-1b).In the Betaseron/Betaferon in Newly Emerging MS For Initial Tr
Autor:
Khatri, B, Barkhof, F, Comi, G, Hartung, Hp, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang auberson, L, Francis, G, Cohen, Ja, Cohen, J, Easton, Jd, Calandra, T, Dimarco, J, Hudson, L, Kesselring, J, Laupacis, A, Temkin, N, Weinshenker, B, Zarbin, M, Poppe, P, Luetic, G, Cristiano, E, Caceres, F, Garcea, O, Correale, J, Ballario, C, Piedrabuena, R, Pollard, J, Beran, R, Hodgkinson, S, Schwartz, R, Heard, R, King, J, Butzkueven, H, Maida, Em, Vass, K, Franta elmer, C, Berger, T, Aichner, F, Ladurner, G, Bissay, V, Sindic, C, D'Hooghe, M, Mulleners, E, Damasceno, B, Barreira, A, Naylor, R, Alvarenga, R, Bacellar, A, Haussen, S, Duquette, P, Antel, J, Lamontagne, A, Grand'Maison, F, Freedman, M, Christie, S, O'Connor, P, Vorobeychik, G, Devonshire, V, Ramadan, M, Hamdy, S, Reda, E, Hashem, S, Fouad, M, Lebrun frenay, C, Clanet, M, Brochet, B, Debouverie, M, Heinzlef, O, Ziemssen, T, Koehler, W, Tiel wilck, K, Bachus, R, Altmann, N, Faiss, J, Baum, K, Dressel, A, Luckner, K, Ebke, M, Stangel, M, Diener, Hc, Bethke, F, Limmroth, V, Maschke, M, Thoemke, F, Reifschneider, G, Diehm, R, Wildemann, B, Melms, A, Rauer, S, Karlbauer, G, Berthele, A, Lang, M, Tumani, H, Krauseneck, P, Klein, M, Papadimitriou, A, Karageorgiou, K, Liakopoulos, D, Tascos, N, Plaitakis, A, Papathanasopoulos, P, Panczel, G, Jakab, G, Csiba, L, Komoly, S, Csanyi, A, Bartos, L, Centonze, D, Pozzilli, C, Marrosu, Mg, Bertolotto, A, Mancardi, GIOVANNI LUIGI, Scarpini, E, Protti, A, Ghezzi, A, Capra, R, Bergamaschi, R, Gallo, P, Stecchi, S, Montanari, E, Tola, Mr, Amato, Mp, Silvestrini, M, Lugaresi, A, Trojano, M, Morra, Vb, Ruggieri, S, Patti, F, Kim, Sm, Lee, Kh, Kim, Hj, Park, Sp, Ginestal, R, Salgado, Av, Fontoura, P, Cunha, L, Sousa, L, Mj, Sá, Pedrosa, R, Arbizu, T, Arroyo, R, Merino, Ja, Fernandez, O, Izquierdo, G, Casanova, B, Antigüedad, A, Goebels, N, Young, C, Lee, M, Chaudhuri, A, Nicholas, R, Martinez, Ac, Preiningerova, J, Greco, D, Gross, J, Newman, S, Mitchell, G, Pawar, G, Freedman, Sm, Kaufman, M, Absher, J, Kantor, D, Ayala, R, Honeycutt, W, Shafer, S, Steingo, B, Delgado, S, Cascione, M, Brock, C, Keegan, A, Laganke, C, Hunter, S, Wilson, E, Mazhari, A, Bauer, W, Singer, B, Lynch, S, Rowe, V, Hutton, G, Gazda, S, Dihenia, B, Campagnolo, D, Chippendale, T, Ash, P, Jung, L, Olek, M.
Publikováno v:
Lancet Neurology, 10(6), 520-529. Lancet Publishing Group
Khatri, B, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang-Auberson, L, Francis, G & Cohen, J A 2011, ' Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study ', Lancet Neurology, vol. 10, no. 6, pp. 520-529 . https://doi.org/10.1016/S1474-4422(11)70099-0
The Lancet Neurology, Vol. 10, no. 6, p. 520-529 (2011)
Khatri, B, Barkhof, F, Comi, G, Hartung, H P, Kappos, L, Montalban, X, Pelletier, J, Stites, T, Wu, S, Holdbrook, F, Zhang-Auberson, L, Francis, G & Cohen, J A 2011, ' Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study ', Lancet Neurology, vol. 10, no. 6, pp. 520-529 . https://doi.org/10.1016/S1474-4422(11)70099-0
The Lancet Neurology, Vol. 10, no. 6, p. 520-529 (2011)
In a 12-month phase 3 study in patients with relapsing-remitting multiple sclerosis (RRMS), TRANSFORMS, fingolimod showed greater efficacy on relapse rates and MRI outcomes compared with interferon beta-1a. We had two aims in our extension: to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b6b2b6d615d53be257bbae8c177cf2
https://research.vumc.nl/en/publications/3df38b4b-0d43-4821-a26d-c5a1be088332
https://research.vumc.nl/en/publications/3df38b4b-0d43-4821-a26d-c5a1be088332
Autor:
Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kovárová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Hartung, Hp, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoff, F, Baum, K, Jung, S, Felicitas Petereit, H, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalbán, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S, Miller, Dh, Polman, Ch, Bauer, L, Ghazi, M, Pohl, C, Sandbrink, R, Barkhof, F, Uitdehaag, B, de Vera, A, Wu, S, Radü, Ew, Mcfarland, Hf, Kesselring, J, Petkau, Aj, Toyka, K. V.
Publikováno v:
Lancet Neurology, 8(11), 987-997. Lancet Publishing Group
Kappos, L, Freedman, M S, Polman, C H, Edan, G, Hartung, H P, Miller, D, Montalban, X, Barkhof, F, Radu, E W, Metzig, C, Bauer, L, Lanius, V, Sandbrink, R & Pohl, C 2009, ' Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial ', Lancet Neurology, vol. 8, no. 11, pp. 987-997 . https://doi.org/10.1016/S1474-4422(09)70237-6
The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)
Kappos, L, Freedman, M S, Polman, C H, Edan, G, Hartung, H P, Miller, D, Montalban, X, Barkhof, F, Radu, E W, Metzig, C, Bauer, L, Lanius, V, Sandbrink, R & Pohl, C 2009, ' Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial ', Lancet Neurology, vol. 8, no. 11, pp. 987-997 . https://doi.org/10.1016/S1474-4422(09)70237-6
The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)
BACKGROUND: The Betaferon/Betaseron in newly emerging multiple sclerosis for initial treatment (BENEFIT) trial investigated the effect of treatment with interferon beta-1b after a clinically isolated syndrome. The 5-year active treatment extension co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32de5c13d4271bf7c0708befa9bfb69e
https://lirias.kuleuven.be/handle/123456789/257768
https://lirias.kuleuven.be/handle/123456789/257768
Autor:
Kappos, L, Freedman, Ms, Polman, Ch, Edan, G, Hartung, Hp, Miller, Dh, Montalbán, X, Barkhof, F, Radü, Ew, Bauer, L, Dahms, S, Lanius, V, Pohl, C, Strasser Fuchs, Sandbrink R. investigators—Austria: S., Graz, T. Berger, Innsbruck, Vass, K., Sindic, V. i. e. n. n. a. Belgium: C., Brussels, B. Dubois, Leuven, D. Dive, Liège, Debruyne, J., Metz, G. h. e. n. t. Canada: L., Calgary, G. Rice, London, Duquette, P., Lapierre, Y., Montreal, M. Freedman, Ottawa, A. Traboulsee, Vancouver, O’Connor, P., Štourač, T. o. r. o. n. t. o. Czech Republic: P., Brno, R. Taláb, Hradec Kralove, O. Zapletalová, Ostrava, Kovářová, I., Medová, E., Prague, Fiedler, J., Frederiksen, P. l. z. e. n. Denmark: J., Brochet, G. l. o. s. t. r. u. p. France: B., Bordeaux, T. Moreau, Dijon, P. Vermersch, Lille, J. Pelletier, Marseille, G. Edan, Rennes, M. Clanet, Toulouse, P. Clavelou, Clermont Ferrand, C. Lebrun Frenay, Nice, Gout, O., Kallela, P. a. r. i. s. Finland: M., Helsinki, T. Pirttilä, Kuopio, J. Ruutiainen, Turku, K. Koivisto, Seinäjoki, M. Reunanen, Oulu, Elovaara, I., Villringer, T. a. m. p. e. r. e. Germany: A., Altenkirch, H., Berlin, K. Wessel, Braunschweig, Hartung, H. P., Steinke, W., Düsseldorf, H. Kölmel, Erfurt, P. Oschmann, Giessen, R. Diem, Göttingen, A. Dressel, Greifswald, F. Hoffmann, Halle/saale, K. Baum, Hennigsdorf, S. Jung, Homburg/saar, Petereit, H., Reske, D., Cologne, M. Sailer, Magdeburg, J. Köhler, Mainz, N. Sommer, Marburg, R. Hohlfeld, Munich, K. H. Henn, Offenbach, A. Steinbrecher, Regensburg, H. Tumani, Ulm, Gold, R., Rieckmann, P., Würzburg, Komoly, R., Gács, G., Jakab, G., Budapest, L. Csiba, Debrecen, Vécsei, L., Miller, S. z. e. g. e. d. Israel: A., Haifa, D. Karussis, Jerusalem, Chapman, J., Ghezzi, Tel H. a. s. h. o. m. e. r. Italy: A., Gallarate, G. Comi, Milan, Gallo, Paolo, V. Cosi, Pavia, Durelli, L., Anten, T. u. r. i. n. Netherlands: B., Sittard, Visser, L., Myhr, T. i. l. b. u. r. g. Norway: K. M., Szczudlik, B. e. r. g. e. n. Poland: A., Kraków, K. Selmaj, Łódź, Z. Stelmasiak, Lublin, R. Podemski, Wrocław, Maciejek, Z., Cunha, B. y. d. g. o. s. z. c. z. Portugal: L., Sega Jazbec, C. o. i. m. b. r. a. Slovenia: S., Montalbán, L. j. u. b. l. j. a. n. a. Spain: X., Arbizu, T., Saiz, A., Barcelona, J. Bárcena, Barakaldo, R. Arroyo, Madrid, O. Fernández, Málaga, G. Izquierdo, Seville, Casanova, B., Lycke, V. a. l. e. n. c. i. a. Sweden: J., Kappos, M. ö. l. n. d. a. l. Switzerland: L., Basel, H. Mattle, Bern, Beer, K., Coleman, St G. a. l. l. e. n. UK: R., Aberdeen, J. Chataway, London, J. O’Riordan, Dundee, S. Howell, Sheffield
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::d69f002d037d3074ebfdce741e09369a
http://hdl.handle.net/11577/1773904
http://hdl.handle.net/11577/1773904